Long-term dupilumab reduces exacerbations and improves lung function in type 2 patients with/without allergic asthma

Autor: Sher, L., Corren, J., Pavord, I., Floquet, S., Pandit-Abid, N., Radwan, A., Jacob-Nara, J., Deniz, Y., Rowe, P.
Zdroj: In Revue Française d'Allergologie April 2023 63(3)
Databáze: ScienceDirect